A significant [area under the curve: 0.729 (0.540–0.919)] efficacy of the anti-TPO 10 cut-off value was observed in the differentiation of patients with stroke localization from the anterior and posterior systems (Figure 1). This evidence concerns the gene TPO and stroke disorder.